Yahoo France Recherche Web

  1. Inclusion des résultats de

    Serous
    Rechercher uniquement Seroug

Résultats de recherche

  1. Il y a 1 jour · Researchers performed a subgroup analysis of 60 eyes diagnosed with acute CSC, and 100 eyes exhibiting chronic central serous chorioretinopathy. Hyperreflective foci appeared in 81% (±15) of eyes with acute disease, and 81% (±20) presenting chronic CSC ( P =.4295).

  2. Il y a 1 jour · L’IL-6, induit par la voie cGAS-STING-RELB délivre un signal de survie dépendant de STAT3. Afin de mieux caractériser les facteurs réellement impliqués dans la moins bonne survie des cellules cGAS KO, et partant du principe que cGAS induit un signal inflammatoire important, les auteurs se sont ensuite intéressés à l’expression des cytokines et notamment de l’IL-6, activateur ...

  3. Il y a 3 jours · Serous effusions were performed with dual-laser 24-color flow cytometric analysis, using NL-CLC full spectrum flow cytometry (Cytek Biosciences, America). A panel containing fluorescein isothiocyanate, or phycoerythrin-conjugated monoclonal antibodies against the following markers were used for diagnosis: CD20, CD19, cCD79a, CD10, CD22, CD23, CD11c, Kappa, Lambda, CD2, CD38, CD5, CD7, CD2, CD3 ...

  4. Il y a 4 jours · Background Ovarian serous cystadenocarcinoma, accounting for about 90% of ovarian cancers, is frequently diagnosed at advanced stages, leading to suboptimal treatment outcomes. Given the malignant nature of the disease, effective biomarkers for accurate prediction and personalized treatment remain an urgent clinical need. Methods In this study, we analyzed the microbial contents of 453 ovarian ...

  5. Il y a 4 jours · It is suggested that microbial profiles in ovarian serous cystadenocarcinoma may serve as viable clinical prognostic indicators and opens avenues for future therapeutic interventions targeting these microorganisms. BACKGROUND Ovarian serous cystadenocarcinoma, accounting for about 90% of ovarian cancers, is frequently diagnosed at advanced stages, leading to suboptimal treatment outcomes ...

  6. Il y a 4 jours · 1 Psaume de David. A l'occasion de sa fuite devant Absalom, son fils. 2 O Eternel, que mes ennemis sont nombreux ! Quelle multitude se lève contre moi! 3 Combien qui disent à mon sujet : Plus de salut pour lui auprès de Dieu !-Pause. 4 Mais toi, ô Eternel ! tu es mon bouclier, Tu es ma gloire, et tu relèves ma tête. 5 De ma voix je crie ...

  7. Il y a 1 jour · Dr. Sanaz Memarzadeh, professor of obstetrics and gynecology and molecular and medical pharmacology at the David Geffen School of Medicine at UCLA and surgeon-scientist in the UCLA Health Jonsson Comprehensive Cancer Center, has received two grants totaling $4.1 million to develop advanced cell based immune therapies for high-grade serous ovarian cancers that have become resistant to ...